Analisis Sistem Pelaporan Monitoring Efek Samping Obat (Meso) Oleh Tenaga Farmasi Di Puskesmas Kota Kendari
Article Sidebar
Main Article Content
Abstract
The extensive use of medicines in healthcare services carries the risk of adverse drug reactions (ADRs) that are not always detected during pre-marketing clinical trials. Therefore, a Monitoring of Adverse Drug Reactions (MESO) reporting system is required in healthcare facilities. This study aims to analyze the influence of knowledge, attitudes, barriers, and facilities on the implementation of MESO reporting by pharmacy personnel at primary health centers (Puskesmas) in Kendari City. The study employed an analytic quantitative cross-sectional design involving 68 pharmacy staff respondents and utilized bivariate chi-square and logistic regression analyses. The results showed that knowledge was not significantly associated with MESO reporting implementation (p=0.147), whereas attitude (p=0.027) and reporting barriers (p=0.004) demonstrated significant associations. Reporting facilities did not have a significant effect (p=0.188). Barriers such as workload and a complicated reporting system emerged as the main issues. In conclusion, optimizing MESO reporting requires strengthening positive attitudes, eliminating key barriers, and developing an integrated system to support sustainable reporting and improve the quality of healthcare services in primary health centers.
Article Details
References
Ade Yulia Ningsih. (2020). Hubungan Antara Tingkat Pengetahuan dan Sikap Apoteker dalam
Pengelolaan Obat Sisa, Obat Rusak dan Obat Kadaluarsa di Apotek Malang Raya.
Adisa, R., & Omitogun, T. I. (2019). Awareness, knowledge, attitude and practice of adverse drug
reaction reporting among health workers and patients in selected primary healthcare centres in
Ibadan, southwestern Nigeria. BMC Health Services Research, 19(1), 1–14.
https://doi.org/10.1186/s12913-019-4775-9
Agoro, O. O., Kibira, S. W., Freeman, J. V, & Fraser, H. S. F. (2018). Barriers to the success of an
electronic pharmacovigilance reporting system in Kenya: an evaluation three years post
implementation. Journal of the American Medical Informatics Association : JAMIA, 25(6), 627–
https://doi.org/10.1093/jamia/ocx102
Alnawaiseh, N. A., & AL-Oroud, R. Y. (2022). Knowledge, Attitude and Practices of
Pharmacovigilance and Adverse Drug Reaction Reporting Among Pharmacists Working at
Alkarak Governorate, Jordan. Biomedical and Pharmacology Journal, 15(2), 967–978.
https://doi.org/10.13005/bpj/2432
Alwidyan, T., Odeh, M., Ibrahim, A. H., Harahsheh, E., & Banat, A. (2025). Knowledge, attitude, and
practice among community pharmacists toward adverse drug reaction reporting and
pharmacovigilance: A nationwide survey. Exploratory Research in Clinical and Social
Pharmacy, 18, 100578. https://doi.org/10.1016/j.rcsop.2025.100578
Barseghyan, A. B., Dzoagbe, H. Y., Nazaryan, L. G., & Simonyan, M. H. (2025). Evaluation of
Pharmacovigilance Awareness, Attitudes, and Reporting Practices of Adverse Drug Reactions in
Community Pharmacies – an Armenian Experience. Farmacia, 73(1), 237–246.
https://doi.org/10.31925/farmacia.2025.1.24
BPOM. (2019). Farmakovigilans (Keamanan Obat) : Panduan Deteksi dan Pelaporan Efek Samping
Obat Untuk Tenaga Kesehatan. Pusat Farmakovigilans Nasional, 1–26.
BPOM. (2020). Modul Farmakovigilans: Dasar Project For Ensuring Drug And Food Safety. Japan
International Cooperation Agency.
BPOM. (2022). Peraturan BPOM Nomor 15 Tahun 2022 tentang Penerapan Farmakovigilans.
Carandang, R. R., Gumop-As, J. G., Andoloy, S. R., Daguman, F. L., Jose, L. J., Villarino, M., &
Quilala, P. (2024). Barriers and Facilitators on Pharmacovigilance Practice Among Pharmacists
in Metro Manila, Philippines. Pharmacoepidemiology and Drug Safety, 33(12), e70072.
https://doi.org/10.1002/pds.70072
Hayek, A., Sridhar, S. B., Rabbani, S. A., Shareef, J., & Wadhwa, T. (2024). Exploring
pharmacovigilance practices and knowledge among healthcare professionals: A cross-sectional multicenter study. SAGE Open Medicine, 12. https://doi.org/10.1177/20503121241249908
Imron, M., & Ananta, S. C. (2024). Strategi Perbaikan Kefarmasian pada Pelayanan Rawat Jalan di
Rumah Sakit Gambiran Kota Kediri. Java Health Journal, 11(1), 1–11.
Kemenkes, D. K. dan A. K. (2023). Petunjuk Teknis Perencaan Kebutuhan Obat.
Khan, Z., Karatas, Y., & Hamid, S. M. (2023). Evaluation of health care professionals’ knowledge,
attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A
cross-sectional multicentral study. PLoS ONE, 18(5 May), 1–27.
https://doi.org/10.1371/journal.pone.0285811
Musdar, T. A., Nadhafi, M. T., Lestiono, L., Lichijati, L., Athiyah, U., & Nita, Y. (2021). Faktor yang
Mempengaruhi Praktik Pelaporan Adverse Drug Reactions (ADRs) oleh Apoteker di Beberapa
Rumah Sakit di Surabaya. JPSCR: Journal of Pharmaceutical Science and Clinical Research,
(2), 96. https://doi.org/10.20961/jpscr.v6i2.49794
Nita, Y., Subakti, B., & Zairina, E. (2005). Pengetahuan dan Sikap Tenaga Kesehatan Terhadap
Pelaporan dan Monitoring Efek Samping Obat di Rumah Sakit. 3–7.
Pebrian, N., Wardani, H. K., & Sumanto, A. B. (2025). Analysis of Factors Influencing Pharmacist
Compliance in Reporting Side Effects of Medications in District Health Center X.
Pharmacovigilance, P., & Wla, A. (2025). Kie farmakovigilans oleh upt badan pom.
S.W.P, F. A., & Rahmawati, F. (2023). Perilaku Apoteker Terhadap Pelaporan Efek Samping Obat.
JURNAL FARMASI Universitas Aisyah Pringsewu Journal Homepage, 99–114. https://journal.aisyahuniversity.ac.id/index.php/JFA/article/download/SKRININGFITOKIMIA/642
Sebastian, R. E., & Ikawati, Z. (2023). Evaluasi Pelaporan Monitoring Efek Samping Obat Beberapa
Rumah Sakit di Daerah Istimewa Yogyakarta. Repository UGM.
https://etd.repository.ugm.ac.id/penelitian/detail/219880
Sultra, B. (2025). Laporan Tahunan Balai POM di Kendari Tahun 2024. 227.